Who is investigating the benefits of SS-31 for heart failure?
The elamipretida, known at the academic level as SS 31, is the subject of intense scrutiny by the international scientific community. Due to its unique ability to stabilize cardiolipin and restore mitochondrial function, several prestigious institutions and biotechnology companies are leading efforts to convert this compound into a standard treatment for heart failure.
Further, the main entities and sectors that lead these investigations are detailed.
STEALTH BIOTHERAPEUTICS AND CLINIC DEVELOPMENT
The main entity behind the commercial development and advanced clinical investigation of elamipretida is Stealth BioTherapeutics. This biotechnology company has led the most significant clinical trials, known as the TANDEM series of studies.
These investigations focus on patients with heart failure with reduced eye fraction and also on those with heart failure with preserved eye fraction. Scientists from this organization collaborate closely with regulatory agencies such as the FDA in the United States to demonstrate that the SS 31 can improve the exercise capacity and quality of life of patients by optimizing the use of energy in the heart.
ACADEMIC INSTITUTIONS AND CENTERS OF EXCELLENCE
In addition to the private sector, prestigious universities and medical research centers around the world carry out independent and collaborative studies to understand the molecular mechanisms of SS 31 in the heart.
– University of Washington: Researchers in Seattle have carried out fundamental studies on how SS 31 reverses mitochondrial dysfunction related to age in the heart, demonstrating that it can improve diastolic function and reduce cardiac fibrosis in biological models.
– Clinic Mayo: This institution has participated in the evaluation of elamipretida, analyzing its impact on reducing oxidative stress and improving the energy efficiency of the left ventricle.
– Cornell University: Investigations centered on the protection of cardiomyocytes (heart muscle cells) against programmed cellular death and damage due to ischemia when using the SS 31 peptide were carried out.
MEDICAL SOCIETIES AND FINANCING BODIES
The importance of these investigations has attracted the support of large public and private organizations that finance wide-ranging studies:
– National Health Institutes (NIH): Through several grants, the government of the United States has financed investigations that explore how the repair of mitochondrial architecture using SS 31 could be a viable strategy for treating chronic heart diseases.
– American Heart Association (AHA): This organization highlights and supports studies that present innovative approaches to heart failure, including therapies that act at the cellular and energetic level rather than simply modifying blood pressure.
CURRENT RESEARCH APPROACHES
Scientists investigating SS 31 on the ground wonder whether the medicine works, under exactly which conditions it is most effective. Currently, research lines are divided into:
– Improvement in Cardiac Bioenergetics: Studying how the peptide allows the heart to produce more ATP (energy) without generating an excess of harmful free radicals.
– Prevention of Cardiac Remodeling: Investigate whether the early use of SS 31 after initial damage can prevent the heart from enlarging and becoming permanently weakened.
– Application in Rare Diseases: Researchers also analyze cardiac benefits in patients with Barth Syndrome, a genetic disease that specifically affects cardiolipin and produces severe heart failure since childhood.
In conclusion, the investigation into SS 31 is a multidisciplinary effort that involves the biotechnology industry, the elite academy and government agencies. Although the results are promising and are in advanced study phases, the scientific community continues working to establish the safest and most effective administration protocols.
SERMORELIN PEPTIDE.
Recommended for improving your health, your well-being and your recovery.
How it works:
Stimulates the pituitary gland to release natural GH, activating the body's physiological production.
For whom is it indicated:
Peopleas con sueño lighto.
Patients with fatigue and low energy.
Men and women older than 30 years.
People looking for gentle anti-aging.
People who want to improve their skin and collagen.
What a improvement:
Deep dream.
Muscle recovery.
Slight increase in muscle mass.
Firmness of the skin.
Energy and vitality.
Sermorelin → smooth and sueño natural GH.
Safe and effective under the supervision of a specialist doctor.
Approved by the FDA.
Tesamorelin peptide.
Powerful for visceral fat and metabolism.
How it works:
Stimulates GH and IGF-1 with greater intensity, improving body composition and reducing persistent abdominal fat.
For whom is it indicated:
Persons with persistent abdominal fat.
Slow metabolism.
From the age of 30-35.
Those looking for performance and aesthetics.
They may find it difficult to gain muscle mass.
What a improvement:
Reduction of visceral fat.
Increase in lean mass.
Deep dream.
Muscle recovery.
Energy and vitality.
Fast metabolism.
Tesamorelin: Visceral fat and metabolism.
Safe and effective under the supervision of a qualified doctor.
Approved by the FDA.
Elamipretide SS-31 peptide.
Mitochondrial peptide: energy, concentration and longevity.
How it works:
It acts directly on the mitochondria, restoring energy efficiency and reducing cellular inflammation.
For whom is it indicated:
Constant fatigue.
Low vitality.
Seniors over 35 years old.
Overworked professionals and sportspeople.
Quienes buscan longevidad.
What a improvement:
ATP energy.
Concentration and mental clarity.
Muscle recovery.
Cellular protection.
Mood and well-being.
Longevity.
SS-31 Mitochondrial energy and deep anti-aging.
Safe and effective if used under the supervision of a qualified doctor.
Approved by the FDA.
Doctor G Medical Excellence: Health, Bienestar and Longevidad
4243 W Hillsboro blvd Coconut Creek, 33073, FL
Phone: +1 (954) 638-1515

Who is investigating the benefits of SS-31 for heart failure?
Route
Doctor G Medical Excellence: Health Well-being and Longevity
Email: drgmed@doctorbgmed.com
URL: https://doctorgmed.com/
| Monday | 09:00 - 17:00 |
| Tuesday | 09:00 - 17:00 |
| Wednesday | 09:00 - 17:00 |
| Thursday | 09:00 - 17:00 |
| Friday | 09:00 - 17:00 |
| Saturday | 09:00 - 17:00 |
| Sunday | Closed |